Concurrent Chemoradiation Lengthens Lung Cancer Survival
May 7th, 2009
NEW YORK (Reuters Health) – Concurrent chemoradiation is associated with the longest survival in patients with advanced non-small cell lung cancer (NSCLC), according to US and Chinese researchers.
However, senior investigator Dr. Feng-Ming Kong of the University of Michigan, Ann Arbor, told Reuters Health, “although high-doseradiation therapy and chemotherapy improve the treatment results, the long-term survival rates from this study remain poor.” She added that survival rates are “much better” in patients treated more recently.